tradingkey.logo
搜尋
市場行情
自選股
新聞
分析
交易工具
選股工具
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜尋

Rigel Pharmaceuticals Inc

RIGL
添加自選
36.815USD
-1.245-3.27%
收盤 07-31 16:00（美東）報價延遲15分鐘
667.97M總市值
1.82本益比TTM

Rigel Pharmaceuticals Inc

36.815
-1.245-3.27%
概覽
財務
分析
公司
財務摘要利潤表資產負債表現金流量表

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

RIGL 財務數據

透過專為投資者打造的一站式數據看板，全面查看 Rigel Pharmaceuticals Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖，助您更輕鬆地進行財務分析。您可以查看最新年度財務報告，也可以通過利潤表、資產負債表和現金流量表，按季度分析公司表現。借助實時財務指標，持續追蹤公司的經營狀況和市場表現更加便捷。

Rigel Pharmaceuticals Inc財報日曆

最新發布
8月 4, 2026
每股收益 / 預測值
--/0.62
營業收入 / 預測值
--/69.46M
查看即將公布的財報
報告期
FY2025 財報
營業收入(YoY)
294.28M
64.15%
每股收益(YoY)
20.40
1951.47%
分析師評級
BUY
2026/07/31
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
財務指標
每股收益
-26.87%0.47
1711.34%14.72
119.16%1.55
5779.21%3.33
236.55%0.64
1821.06%0.81
316.22%0.71
84.55%-0.06
39.65%-0.47
-57.70%0.04
---0.33
---0.38
---0.78
--0.10
---3.48
----
----
----
----
----
營業收入
10.28%58.82M
21.19%69.80M
25.59%69.46M
176.01%101.69M
80.58%53.33M
60.92%57.60M
96.58%55.31M
37.03%36.84M
13.29%29.53M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
151.25%51.28M
4.02%22.41M
13.53%29.82M
-79.34%16.73M
10.62%20.41M
17.15%21.54M
63.95%26.27M
淨利潤
-24.39%8.65M
1769.22%268.06M
124.62%27.90M
5887.67%59.61M
238.79%11.45M
1845.86%14.34M
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
-47.39%737.00K
70.10%-5.69M
51.08%-6.60M
50.68%-13.54M
106.19%1.40M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
-17.70%-22.64M
-47.82%-20.95M
21.36%-13.82M
利潤率
-31.44%14.71%
1442.36%384.04%
78.85%40.17%
2196.90%58.63%
176.86%21.46%
1109.22%24.90%
211.01%22.46%
88.61%-2.80%
46.22%-27.92%
-24.63%2.06%
---20.23%
---24.55%
---51.92%
--2.73%
---86.96%
----
----
----
----
----
毛利率
0.48%92.17%
1.69%91.47%
8.97%93.16%
3.45%95.57%
-1.51%91.73%
0.60%89.95%
-10.48%85.49%
-3.77%92.38%
-3.23%93.14%
-9.99%89.41%
--95.49%
--96.00%
--96.25%
--99.33%
--97.96%
----
----
----
----
----
資產負債率
-73.82%8.89%
-72.02%10.18%
-42.55%24.63%
-37.76%28.93%
-28.04%33.95%
-28.42%36.40%
-17.14%42.87%
-8.63%46.49%
-1.96%47.18%
73.07%50.84%
--51.73%
--50.88%
--48.12%
--29.38%
--34.14%
----
----
----
----
----
利潤表
營業收入
10.28%58.82M
21.19%69.80M
25.59%69.46M
176.01%101.69M
80.58%53.33M
60.92%57.60M
96.58%55.31M
37.03%36.84M
13.29%29.53M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
151.25%51.28M
4.02%22.41M
13.53%29.82M
-79.34%16.73M
10.62%20.41M
17.15%21.54M
63.95%26.27M
營業利潤
-6.95%11.88M
39.12%23.17M
102.19%28.42M
13569.57%61.10M
283.36%12.77M
747.15%16.66M
414.80%14.06M
108.49%447.00K
45.26%-6.97M
-42.16%1.97M
75.74%-4.46M
59.38%-5.27M
51.54%-12.72M
118.99%3.40M
6.99%-18.40M
0.64%-12.96M
-162.89%-26.26M
4.94%-17.90M
-43.57%-19.79M
24.98%-13.05M
淨利潤
-24.39%8.65M
1769.22%268.06M
124.62%27.90M
5887.67%59.61M
238.79%11.45M
1845.86%14.34M
318.22%12.42M
84.39%-1.03M
39.07%-8.25M
-47.39%737.00K
70.10%-5.69M
51.08%-6.60M
50.68%-13.54M
106.19%1.40M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
-17.70%-22.64M
-47.82%-20.95M
21.36%-13.82M
資產負債表
流動資產
59.68%234.03M
77.77%240.17M
101.87%214.93M
85.16%175.39M
58.47%146.56M
36.10%135.10M
12.04%106.47M
-6.15%94.72M
-13.54%92.49M
-14.35%99.27M
-13.96%95.02M
-16.26%100.92M
-23.01%106.97M
-24.97%115.90M
-35.45%110.44M
-34.57%120.52M
-29.39%138.94M
73.59%154.47M
71.36%171.10M
62.88%184.20M
流動負債總額
34.31%89.49M
56.77%99.24M
73.81%94.40M
47.72%86.64M
-8.97%66.63M
18.83%63.30M
12.51%54.31M
33.22%58.65M
60.81%73.20M
-18.32%53.27M
2.13%48.27M
-19.89%44.02M
-23.14%45.52M
2.61%65.21M
-20.27%47.27M
-7.71%54.95M
13.85%59.23M
55.61%63.55M
73.38%59.28M
71.30%59.54M
總資產
186.75%504.61M
213.21%513.59M
73.96%242.53M
61.00%206.74M
39.09%175.97M
39.88%163.98M
20.89%139.42M
9.67%128.41M
2.35%126.52M
-12.70%117.22M
-0.25%115.32M
-8.52%117.09M
-17.08%123.61M
-19.75%134.28M
-38.02%115.61M
-36.51%128.00M
-30.98%149.07M
51.60%167.33M
51.57%186.52M
46.05%201.60M
總負債
-33.48%104.71M
-24.01%122.11M
-18.91%124.92M
-21.17%124.80M
-0.50%157.41M
10.16%160.69M
4.69%154.06M
9.03%158.32M
6.98%158.19M
-1.37%145.87M
8.65%147.16M
10.27%145.21M
3.93%147.87M
7.99%147.90M
-1.03%135.44M
-1.36%131.68M
3.33%142.28M
79.37%136.95M
89.80%136.85M
78.40%133.49M
總權益
2053.81%399.90M
11806.33%391.48M
903.56%117.61M
373.90%81.93M
158.62%18.57M
111.48%3.29M
54.02%-14.64M
-6.40%-29.91M
-30.56%-31.67M
-110.37%-28.64M
-60.50%-31.83M
-664.62%-28.11M
-456.83%-24.26M
-144.83%-13.62M
-139.93%-19.83M
-105.40%-3.68M
-91.32%6.80M
-10.73%30.37M
-2.52%49.67M
7.75%68.11M
現金流量表
經營淨額
405.15%2.73M
51.55%21.98M
10.85%24.03M
10011.59%30.54M
82.19%-893.00K
332.42%14.50M
1695.22%21.68M
-94.91%302.00K
-23.05%-5.01M
71.52%-6.24M
89.78%-1.36M
145.93%5.93M
84.11%-4.07M
-14.79%-21.91M
-29.17%-13.30M
-123.38%-12.91M
-28.47%-25.64M
-22.57%-19.09M
47.15%-10.30M
493.33%55.22M
投資淨額
24.42%-7.97M
-132.38%-25.36M
-972.57%-33.17M
-312.97%-23.28M
-3471.25%-10.55M
-58.77%-10.91M
424.96%3.80M
267.98%10.93M
-59.72%313.00K
-136.96%-6.87M
-111.19%-1.17M
-85.92%2.97M
-96.57%777.00K
186.65%18.60M
123.55%10.46M
142.48%21.09M
200.44%22.63M
-25.52%6.49M
-327.35%-44.40M
-848.78%-49.66M
融資淨額
-2355.99%-10.92M
-412.08%-4.57M
143.40%4.27M
155.59%418.00K
119.27%484.00K
201.44%1.47M
-1032.57%-9.84M
-101.61%-752.00K
-113.14%-2.51M
123.19%486.00K
-115.77%-869.00K
93.41%-373.00K
117.38%19.12M
-293.18%-2.10M
1911.31%5.51M
-109.56%-5.66M
319.50%8.80M
62.67%1.08M
426.92%274.00K
463.13%59.22M

常見問題

Rigel Pharmaceuticals Inc的總收入是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，總收入達到294.28M（同比變化179.28M）。

Rigel Pharmaceuticals Inc的流動資產是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，流動資產為240.17M（同比變化77.77）。

Rigel Pharmaceuticals Inc的總資產是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，Rigel Pharmaceuticals Inc的總資產為513.59M（同比變化213.21）。

Rigel Pharmaceuticals Inc的總負債是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，Rigel Pharmaceuticals Inc的總責任為122.11M（同比變化-24.01）。

Rigel Pharmaceuticals Inc的總權益是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，Rigel Pharmaceuticals Inc的總權益為391.48M（同比變化11806.33）。

Rigel Pharmaceuticals Inc的淨營業收入是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，Rigel Pharmaceuticals Inc的淨營業收入為125.47M（同比變化418.63）。

Rigel Pharmaceuticals Inc的淨投資是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，Rigel Pharmaceuticals Inc的淨投資為-92.36M（同比變化-2336.44）。

Rigel Pharmaceuticals Inc的淨融資是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，Rigel Pharmaceuticals Inc的淨融資為601.00K（同比變化105.16）。

Rigel Pharmaceuticals Inc的每股收益（EPS）是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，每股收益（EPS）為20.40（同比變化1951.47）。

Rigel Pharmaceuticals Inc的淨利潤是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，淨利潤為367.02M（同比變化1999.08）。

Rigel Pharmaceuticals Inc的淨利潤率是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，淨利潤率為124.72（同比變化1178.77）。

Rigel Pharmaceuticals Inc的毛利率是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，毛利率為93.33（同比變化4.17）。

Rigel Pharmaceuticals Inc的債務與資產比率是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，債務與資產比率為10.18（同比變化-72.02）。

Rigel Pharmaceuticals Inc的資產回報率（ROA）是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，資產回報率（ROA）為108.34（同比變化771.15）。

Rigel Pharmaceuticals Inc的營業利潤是多少？

根據Rigel Pharmaceuticals Inc的FY2025財報，營業利潤為125.47M（同比變化418.63）。
tradingkey.logo
風險提示：我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦，且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險，包括可能損失投資的本金，且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告，並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有
一般使用條款
隱私權政策
Cookie政策